DIFFERENTIAL EFFECTS OF SMOKING ON LONG-TERM OUTCOMES IN PATIENTS WITH ATHEROSCLEROTIC VASCULAR DISEASE TREATED WITH ASPIRIN OR CLOPIDOGREL: INSIGHTS FROM THE CLOPIDOGREL VERSUS ASPIRIN IN PATIENTS AT RISK OF ISCHEMIC EVENTS TRIAL

被引:0
|
作者
Ferreiro, Jose Luis [1 ]
Bhatt, Deepak [1 ]
Ueno, Masafumi [1 ]
Bauer, Deborah [1 ]
Angiolillo, Dominick [1 ]
机构
[1] Univ Florida, Coll Med Jacksonville, Jacksonville, FL USA
关键词
D O I
10.1016/S0735-1097(12)60258-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E257 / E257
页数:1
相关论文
共 50 条
  • [41] Thrombin formation and platelet activation at the site of vascular injury in patients with coronary artery disease treated with clopidogrel combined with aspirin
    Undas, Anetta
    Stepien, Ewa
    Branicka, Agnieszka
    Wolkow, Pawel
    Zmudka, Krzysztof
    Tracz, Wieslawa
    KARDIOLOGIA POLSKA, 2009, 67 (06) : 591 - 598
  • [42] The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden
    Lindgren, P
    Stenestrand, U
    Malmberg, K
    Jönsson, B
    CLINICAL THERAPEUTICS, 2005, 27 (01) : 100 - 110
  • [43] Cost-effectiveness of clopidogrel addition to aspirin to prevent cardiovascular events in patients with established cardiovascular disease: results from the CHARISMA trial
    Bakhai, A.
    Chen, J.
    Schneider, E.
    Bhatt, D. L.
    De Pouvourville, G.
    Willich, S. N.
    Caro, J.
    Hacke, W.
    Fox, K. A. A.
    Cohen, D. J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 858 - 858
  • [44] Cardiovascular effects of hormone replacement therapy in post menopausal women in CAPRIE: Clopidogrel versus Aspirin in Patients at Risk of Ishemic Events study.
    Simon, T
    Dukovic, D
    Jaillon, P
    CIRCULATION, 2000, 102 (18) : 838 - 838
  • [45] Cost-effectiveness of clopidogrel versus aspirin in the prevention of ischemic events in stroke and tia patients: A four-European country analysis
    Palmer, AJ
    Roze, S
    Hankey, G
    Hakimi, Z
    Spiesser, J
    Carita, P
    Gabriel, S
    VALUE IN HEALTH, 2005, 8 (03) : 334 - 334
  • [47] PHARMACODYNAMIC EFFECTS OF ADJUNCTIVE CLOPIDOGREL THERAPY IN PATIENTS WITH ATHEROSCLEROTIC DISEASE ON DUAL PATHWAY INHIBITION WITH ASPIRIN AND LOW-DOSE RIVAROXABAN
    Franchi, Francesco
    Rollini, Fabiana
    Been, Latonya
    Abou Jaoude, Patrick
    Rivas, Andrea
    Zhou, Xuan
    Jia, Sida
    Maaliki, Naji
    Lee, Chang Hoon
    Maldonado, Andres Pineda
    Suryadevara, Siva
    Soffer, Daniel
    Zenni, Martin
    Jennings, Lisa
    Bass, Theodore
    Angiolillo, Dominick
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1187 - 1187
  • [48] Long-Term Outcomes by Clopidogrel Duration in a Diabetic Patients treated with Drug-eluting stent
    Seo, Jeong-Sook
    Park, Duk-Woo
    Kim, Sung Sik
    Kim, Sung-Hwan
    Yi, Myung-Zoon
    Lee, Seung-Whan
    Kim, Young-Hak
    Lee, Cheol Whan
    Hong, Myeong-Ki
    Kim, Jae-Joong
    Park, Seong-Wook
    Park, Seung-Jung
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A13 - A13
  • [49] Clopidogrel versus aspirin in high-risk patients with recent ischemic stroke or transient ischemic attack: Cost-effectiveness analysis in Italy
    Rudelli, G
    Roze, S
    Palmer, AJ
    Hakimi, Z
    Spiesser, J
    Carita, P
    Gabriel, S
    VALUE IN HEALTH, 2005, 8 (06) : A151 - A151
  • [50] Cost-effective analysis of clopidogrel versus aspirin for high risk patients with established peripheral arterial disease in China
    Lin, Ziyi
    Zhang, Lei
    Yang, Xiaoyan
    Liu, Li
    Xuan, Jianwei
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (06) : 659 - 666